BRAINLIFE.ORG




Neuro-Oncology Reviews




Volume 25 Number 20
31 October 2023




Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 20, 31 October






Dang DD, Gong AD, Dang JV, Mugge LA, Mansinghani S, Ziu M, Cohen AL, Vyas N.
Systematic Review of WHO Grade 4 Astrocytoma in the Cerebellopontine Angle: The Impact of Anatomic Corridor on Treatment Options and Outcomes.
J Neurol Surg Rep. 2023 Oct 16;84(4):e129-e139. doi: 10.1055/a-2172-7770. PMID: 37854309. Review.
ˍ




Jiang S, Chai H, Tang Q, Shi Z, Zhou L.
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review.
Discov Oncol. 2023 Oct 16;14(1):183. doi: 10.1007/s12672-023-00769-1. PMID: 37845388. Review.
ˍ




Rüther M, Hagan AJ, Verity SJ.
The role of CNS tumor location in health-related quality of life outcomes: A systematic review of supratentorial vs infratentorial tumors in childhood survivorship.
Appl Neuropsychol Child. 2023 Oct 18:1-20. doi: 10.1080/21622965.2023.2268776. PMID: 37851360. Review˰
ˍ




Fu AY, Gutha A, Ammar A, Collins JJ, Mazzola CA.
The landscape of current research on pediatric diffuse midline glioma: a quantitative analysis of shifts, leaders, and future avenues.
Childs Nerv Syst. 2023 Oct 19. doi: 10.1007/s00381-023-06178-7. PMID: 37855876. Review˰
ˍ




Peddinti V, Rout B, Agnihotri TG, Gomte SS, Jain A.
Functionalized liposomes: an enticing nanocarrier for management of glioma.
J Liposome Res. 2023 Oct 19:1-19. doi: 10.1080/08982104.2023.2270060. PMID: 37855432. Review˰
ˍ




Schaefer MR.
Unforeseen Gifts: Seeking meaning while caring for children diagnosed with DIPG.
Pediatr Blood Cancer. 2023 Oct 19:e30729. doi: 10.1002/pbc.30729. PMID: 37856136. Perspective.
ˍ




Taylor KR, Monje M.
Neuron-oligodendroglial interactions in health and malignant disease.
Nat Rev Neurosci. 2023 Oct 19. doi: 10.1038/s41583-023-00744-3. PMID: 37857838. Review˰ ˍ




Barbotin M, Thoreau V, Page G.
Brain tumours: non-invasive techniques to treat invasive pathologies.
Ann Pharm Fr. 2023 Oct 20:S0003-4509(23)00131-1. doi: 10.1016/j.pharma.2023.10.004. PMID: 37866636. Review˰
ˍ




Dewdney B, Jenkins MR, Best SA, Freytag S, Prasad K, Holst J, Endersby R, Johns TG.
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress.
Signal Transduct Target Ther. 2023 Oct 20;8(1):400. doi: 10.1038/s41392-023-01637-8. PMID: 37857607. Review.
ˍ




Lakhani DA, Sabsevitz DS, Chaichana KL, Quiñones-Hinojosa A, Middlebrooks EH.
Current State of Functional MRI in the Presurgical Planning of Brain Tumors.
Radiol Imaging Cancer. 2023 Oct 20;5(6):e230078. doi: 10.1148/rycan.230078. PMID: 37861422. Review.
ˍ




Bhatia A, Sabin ND, Fisher MJ, Poussaint TY.
Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
Pediatr Radiol. 2023 Oct 21. doi: 10.1007/s00247-023-05780-w. PMID: 37864711. Review˰ ˍ



*

Gupta N, Godbole N, Sanmugananthan P, Gunda S, Kasula V, Baggett M, Gajjar A, Kouam RW, D'Amico R, Rodgers S.
Management of Atypical Teratoid/Rhabdoid Tumors in the Pediatric Population: A Systematic Review and Meta-Analysis.
World Neurosurg. 2023 Oct 21:S1878-8750(23)01495-X∟. doi: 10.1016/j.wneu.2023.10.089∟. PMID: 37871692∟. Review, Meta-analysis˰
ˍ




Iyengar V, Agrawal S, Chiasakul T, Tehranchi K, Mcnichol M, Carney BJ, Leader A, Zwicker JI, Patell R.
Comparison of Direct Oral Anticoagulants versus Low Molecular Weight Heparin in Primary and Metastatic Brain Cancers: A Meta-Analysis and Systematic Review.
J Thromb Haemost. 2023 Oct 21:S1538-7836(23)00779-1. doi: 10.1016/j.jtha.2023.10.011. PMID: 37866517. Review, Meta-analysis˰
ˍ




Jabehdar Maralani P, Chan RW, Lam WW, Oakden W, Oglesby R, Lau A, Mehrabian H, Heyn C, Chan AKM, Soliman H, Sahgal A, Stanisz GJ.
Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know.
Technol Cancer Res Treat. 2023 Oct 23;22:15330338231208613. doi: 10.1177/15330338231208613. PMID: 37872686. Review.
ˍ



*

Lang M, Colby S, Ashby-Padial C, Bapna M, Jaimes C, Rincon SP, Buch K.
An imaging review of the hippocampus and its common pathologies.
J Neuroimaging. 2023 Oct 23. doi: 10.1111/jon.13165. PMID: 37872430. Review˰
ˍ




Bao J, Pan Z, Wei S.
Initial Treatment of IDH-Wildtype Glioblastoma in Adults Older Than 70 Years.
Cureus. 2023 Oct 24;15(10):e47602. doi: 10.7759/cureus.47602. PMID: 37881322. Review.
ˍ




Jucht A, Dumont S, Pooley C, Gonzalez Castro LN.
Cancer vaccine strategies for the treatment of diffusely infiltrating gliomas.
Ther Adv Vaccines Immunother. 2023 Oct 24;11:25151355231206163. doi: 10.1177/25151355231206163. PMID: 37886714. Review.
ˍ




Kang W, Mo Z, Li W, Ma H, Zhang Q.
Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review).
Oncol Rep. 2023 Oct 25;50(6):217. doi: 10.3892/or.2023.8654. PMID: 37888767. Review.
ˍ



*

Blanchard R, Adjei I.
Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.
RSC Adv. 2023 Oct 27;13(45):31411-31425. doi: 10.1039/d3ra01153d. PMID: 37901257. Review.
ˍ



*

Crompton D, Koffler D, Fekrmandi F, Lehrer EJ, Sheehan JP, Trifiletti DM.
Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04466-5. PMID: 37889441. Review.
ˍ




Michaelson NM, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA.
Disparities in Neuro-Oncology.
Curr Neurol Neurosci Rep. 2023 Oct 27. doi: 10.1007/s11910-023-01314-x. PMID: 37889427. Review˰
ˍ



*

Szabados M, Kolumbán E, Agócs G, Kiss-Dala S, Engh MA, Hernádfői M, Takács K, Tuboly E, Párniczky A, Hegyi P, Garami M.
Association of tumor location with anxiety and depression in childhood brain cancer survivors: a systematic review and meta-analysis.
Child Adolesc Psychiatry Ment Health. 2023 Oct 27;17(1):124. doi: 10.1186/s13034-023-00665-0. PMID: 37891679. Review, Meta-analysis.
ˍ




Rechberger JS, Bouchal SM, Power EA, Nonnenbroich LF, Nesvick CL, Daniels DJ.
Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies.
Expert Opin Ther Targets. 2023 Oct 28:1-16. doi: 10.1080/14728222.2023.2277232. PMID: 37897190. Review˰
ˍ